Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial
This makes managing your health easier and more convenient than ever
With consistent use, thinning areas appear fuller, hair feels stronger at the root, and overall scalp health improves for long-term growth support
Mild nausea or a temporary drop in blood pressure
PDA + GHK-Cu protocol: PDA: 500 mcg subcutaneous or oral, once daily GHK-Cu: Per standard dosing guidelines (varies by administration route) Duration: 4 to 8 weeks PDA + SS-31 (Elamipretide) For researchers focused on mitochondrial health and cellular energy, combining penta deca peptide arginate with SS-31 creates a protocol that addresses tissue repair from both structural and energetic perspectives
A 2.5 mg dose is 2,500 mcg, which at this concentration is 0.75 mL 75 units on a U-100 syringe